Newstral
Article
bizjournals.com on 2021-07-29 11:16
Amid a sea of IPOs, here's why Gelesis opted for the SPAC route
Related news
- Why seven biotech startups have opted for the SPAC route in 2021bizjournals.com
- Here's why T.J. Rodgers hates IPOs and loves Enovix, the company his SPAC is taking publicbizjournals.com
- SEC’s First Quarter Rules: SPAC IPOs and Climate Disclosure Mandatesjdsupra.com
- BSPAC IPOs Fall Out of Favor After Hot Streakbarrons.com
- Treat Like as Like? SEC Adopts Final Rules for SPAC IPOs and de-SPAC Transactionsjdsupra.com
- SEC Adopts Final Rules Regarding SPAC IPOs and SPAC Business Combinationsjdsupra.com
- BSPAC IPOs Are on the Rise. Here’s Why.1 min readbarrons.com
- Clean Energy IPOs And SPAC Combinations: Historical Trends And Future Possibilitiesjdsupra.com
- The Funded: 11 Bay Area fundings, 4 IPOs and 3 SPAC deals at week's endbizjournals.com
- The Funded: SPAC IPOs are dwindling, but 'blank check' mergers continue apacebizjournals.com
- Highly valued startups did SPAC deals or completed IPOs after getting PPP loansbizjournals.com
- Trump Media Market Moves Show Why You Don’t Buy IPOs Or SPAC CompaniesForbes
- Why SPAC IPOs may delay the lockup period for privately held companies they acquirebizjournals.com
- Khosla Ventures gets into the SPAC boom with plans to raise $1.2B in 3 IPOsbizjournals.com
- Digital health startup Hims & Hers eyes SPAC route to IPObizjournals.com
- Tech is still on the SPAC train. Here's whybizjournals.com
- [Webinar] What’s Driving Transition Energy IPOs and SPAC Combinations? - November 4th, 12:00 pm - 1:00 pm CTjdsupra.com
- Fenwick’s Going Public Report: Covering U.S. Technology and Life Sciences IPOs, de-SPAC Mergers and Direct Listings - 2021 H1jdsupra.com